Pfizer

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The company is headquartered in New York City, New York and currently employs 75,000 full-time employees.  The firm is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, and others. Its PF-08653944 is an ultra-long-acting fully biased GLP-1 receptor agonist.

Pfizer Inc. adalah perusahaan biopharmaceutical global yang berbasis riset, yang terlibat dalam penemuan, pengembangan, produksi, pemasaran, penjualan, dan distribusi produk biopharmaceutical di seluruh dunia. Perusahaan ini berkantor pusat di New York City, New York, dan saat ini mempekerjakan 75.000 karyawan penuh waktu. Perusahaan ini terlibat dalam penemuan, pengembangan, produksi, pemasaran, penjualan, dan distribusi produk biopharmaceutical di seluruh dunia. Segmen Biopharma-nya mencakup Divisi Komersial Pfizer AS dan Divisi Komersial Internasional Pfizer. Kategori produknya mencakup onkologi, perawatan primer, dan perawatan spesialis. Produk onkologinya meliputi Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, dan Talzenna. Produk perawatan primernya meliputi Eliquis, Nurtec ODT/Vydura, Zavzpret, keluarga Prevnar, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, dan Paxlovid. Produk perawatan spesialisnya meliputi Xeljanz, Enbrel (di luar Amerika Serikat dan Kanada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, keluarga Vyndaqel, Genotropin, dan lainnya. PF-08653944 adalah agonis reseptor GLP-1 yang sangat lama bertindak dan sepenuhnya bias.

Pfizer Stock

About Pfizer

Key Statistics

Insights